Biocept, Inc.
BIOCQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.63M | -7.14M | -9.71M | -14.36M | -10.05M |
| Total Depreciation and Amortization | 370.00K | 614.00K | 438.00K | 407.00K | -9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.52M | 316.00K | 561.00K | 127.00K | 853.00K |
| Change in Net Operating Assets | 1.69M | 20.00K | 4.47M | 9.75M | 5.16M |
| Cash from Operations | -3.09M | -6.19M | -4.24M | -4.08M | -4.04M |
| Capital Expenditure | -97.00K | -91.00K | -136.00K | -356.00K | -217.00K |
| Sale of Property, Plant, and Equipment | 75.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.00K | -91.00K | -136.00K | -356.00K | -217.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -591.00K | -234.00K | -747.00K | -621.00K | -475.00K |
| Issuance of Common Stock | 3.56M | 396.00K | 1.00K | 145.00K | 94.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.97M | 162.00K | -746.00K | -476.00K | -381.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -141.00K | -6.12M | -5.12M | -4.91M | -4.64M |